Nickan Research Institute Journal of Renal Injury Prevention 2345-2781 2 3 2013 09 10 Ticlopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial 109 111 10.12861/jrip.2013.35 EN Ali Ghorbani Farzad Jasemi-Zergani LETTER 10.12861/jrip.2013.35 Implication for health policy/practice/research/medical education:Primary arteriovenous fistula (AVF), failure remains a major problem for hemodialysis patients. Vascular access thrombosis prophylaxis needs to start early in the end-stage renal disease patient. Ticlopidine seems to be effective and safe for prevention of primary AVF failure in hemodialysis patients.